Skip to main content

Table 3 Clinical and endocrine characteristics, by PCOS phenotype

From: Polycystic ovary syndrome phenotype does not have impact on oocyte morphology

PCOS B (n = 1) was excluded

PCOS A

N = 41

PCOS C

N = 31

PCOS D

N = 37

p value

Woman’s age at first ICSI cycle (y)

29.2 ± 3.2

28.6 ± 4.1

29.1 ± 3.4

0.77

Man’s age (y)

32.9 ± 4,5

32.0 ± 7,2

32.6 ± 4,5

0.80

Current smoking, n (%)

9 (22.0)

14 (45.2) c

5 (13.5) b

0.009

BMI (kg/m2)

27.7 ± 6.7

26.4 ± 6.0

26.3 ± 5.0

0.48

Waist circumference (cm)

86.6 ± 16.3

84.0 ± 14.8

84.6 ± 12.8

0.74

Testosterone (ng/mL)

0.4 ± 0.2c

0.3 ± 0.2

0.3 ± 0.1a

0.004

Delta-4-androstenedione (ng/mL)

2.3 ± 0.7c

2.1 ± 0.7c

1.3 ± 0.4ab

< 0.001

LH (IU/L)

5.6 ± 2.6 bc

4.1 ± 1.9a

4.2 ± 2.0a

0.006

FSH (IU/L)

4.8 ± 1.1

5.2 ± 1.4

4.7 ± 1.0

0.23

LH/FSH ratio (IU/L)

1.1 [0.9-1.4] bc

0.8 [0.6-1.0] a

0.8 [0.7-1.2] a

< 0.001

AMH (pmol/L)

74.8 ± 37.4 bc

47.3 ± 17.1a

56.2 ± 19.9a

< 0.001

FNPO (n)

26.8 ± 10.1

21.7 ± 8.2

23.1 ± 8.0

0.042

  1. Values are quoted as the mean ± standard deviation, the mean [IQR], or n (%)
  2. a p < 0.05 vs. PCOS A after Bonferroni correction
  3. b p < 0.05 vs. PCOS C after Bonferroni correction
  4. c p < 0.05 vs. PCOS D after Bonferroni correction
  5. Abbreviations: y years, BMI body mass index, LH luteinizing hormone, FSH follicle-stimulating hormone, IQR interquartile range, AMH anti-Müllerian hormone, FNPO follicle number per ovary